Ennature Biopharma’s Maxicuma and Xanthogreen achieve Clean Label Project certification

Published: 28-Apr-2025

Ennature Biopharma’s Maxicuma and Xanthogreen achieve Clean Label Project certification, reinforcing its commitment to purity and transparency

Ennature Biopharma, a leading innovator in plant-based nutraceutical ingredients, is proud to announce that two of its flagship ingredients—Maxicuma® (a high-bioavailable curcumin extract) and Xanthogreen® (fast acting lutein esters)—have received Clean Label Project™ certification, underscoring the company’s commitment to safety, transparency, and quality.

The Clean Label Project, a non-profit organisation, evaluates products for industrial and environmental contaminants and benchmarks them against the best-in-class. Receiving this certification confirms that Maxicuma® and Xanthogreen® meet the highest quality standards in the nutraceutical industry.

Scientifically validated efficacy meets clean label purity

Maxicuma®, is a clinically validated curcumin extract, for its superior bioavailability and efficacy, at an ultra-low dose of 100- 250 mg per day. Maxicuma® is standardised to contain 40% curcuminoids and researched for its strong anti-inflammatory and antioxidant benefits. The ingredient is certified with self-affirmed GRAS by an independent scientific panel.

Visit website

Xanthogreen®, is a specialty lutein ester derived from marigold flowers through supercritical fluid extraction, without use of any harsh chemicals or solvents in the process. The ingredient has shown clinical efficacy in improving macular pigment density (MPOD) and overall eye health in just four weeks—making it as the preferred natural solution for eye health formulations.

Visit website

The Clean Label Project certification for Maxicuma® and Xanthogreen®, allows brand formulators to source ingredients that comply with stringent quality standards and meet the retail consumer expectations.

Relevant companies

You may also like